13/05/2017 6o Συνέδριο Διακαθετηριακής Θεραπείας Καρδιακών Βαλβιδοπαθειών | V.Ninios | 1. MitraClip patient selection- what are the limits on good outcomes in FMR

 
1,139 VIEWS EXPANDCOLLAPSE PRESENTATION

Share

195,752 total
535 live
1,139 video
90,056 photo
Views:

09:00-11:00 Mitral club II
Πρόεδροι: S.Adamopoulos,G.Filippatos,A.Trikas
09:00-09:15 1. MitraClip patient selection- what are the limits on good outcomes in FMR
V.Ninios
09:15-09:30 2. MitraClip patient selection- what are the limits on good outcomes in DMR
M.Chrissoheris
09:30-09:45 3. Mitral interventions: a new challenge for structural interventionalists. How to learn mitral interventions
G.Pavlides
09:45-10:00 4. Surgical MV replacement and repair in FMR. State of the art (reality vs. the CTSNET and STICH-iMR trials)
P.Ponikowski
10:00-10:15 5. Innovation breaking news
K.Spargias
10:15-10:30 6. Which “operable” DMR patient I will opt for transcatheter therapy and why? Should we Surgeons make the first step this time?
S.Pattakos
10:30-10:45 7. Mitraclip case-in-a-box
K.Spargias
10:45-11:00 Συζήτηση


Watch live and on demand the '6th Conference of  Transcatheter Heart Valve Therapies'.
​
The Diagnostic and Therapeutic Center of Athens Hygeia organizes the '6th Conference of  Transcatheter Heart Valve Therapies' that will take place from 12 to 13 May 2017, at Hilton Hotel in Athens, Greece.

For more information please click here.

Παρακολουθήστε ζωντανά και on demand το '6ο Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών'.

Το Διαγνωστικό Θεραπευτικό Κέντρο Αθηνών ΥΓΕΙΑ διοργανώνει το '6o Συνέδριο Διαδερμικής Θεραπείας Καρδιακών Βαλβιδοπαθειών' στις 12 - 13 Μαΐου 2017 στο ξενοδοχείο Hilton στην Αθήνα.

Για περισσότερες πληροφορίες, πατήστε εδώ.
 
Sort by Date | Views
A.Manginas | 1. The foundation of a new... 1.240
K.Spargias | 2. TAVR: The device evolution... 1.316
K.Toutouzas | 3. TAVR: The constantly changing... 1.143
G.Latsios | 4. What is the reasonable training... 1.228
K.Bellos | 5. What is the reasonable training... 1.144
A.Manolis | 6. Who should be performing... 1.856
I.Iakovou | 7. TAVI live case-in-a-box 1.372
S.Pattakos 1.121
460
D.Cokkinos 1.271
A.Kartapanis 1.081
I.Goudevenos 1.105
Στρατής Παττακός | Καρδιοχειρουργός, Διευθυντής... 1.382
1:24
Στέφανος Φούσας | Σ. Διευθυντής - Ε. Καθηγητής... 963
2:31
C.Mourmouris | 1. MSCT screening. Guidance,... 1.071
Catherine Avgeropoulou, Cardiologist, Director,... 1.139
1:49
Konstantinos Toutouzas | Associate Professor... 1.384
2:08
G.Latsios | 2. TF access today: vessel,... 1.023
Gregory Pavlides | MD, PhD, FACC, FESC, Professor... 1.264
2:08
N.Bouboulis | 3. Unanimous verdict: non... 1.062
V.Tzifos | 4. Concomitant coronary artery... 1.043
E.Skalidis | 5. The advanced renal failure... 1.175
K.Toutouzas | 6. The procedure was flawless... 1.142
K.Spargias | 7. TAVR live-in-a-box 1.183
C.Avgeropoulou | 1. A “Physiologist’s” view... 1.206
C.Chrysohoou | 2. From clinical practice... 1.156
G.Makos | 4. MR Surgery. When to repair... 1.169
G.Pavlides | 5. Trancatheter MV replacement.... 1.141
K.Spargias | 6. MAC and ViV, ViR 1.089
K.Spargias | 7. Mitraclip case-in-a-box 1.211
K.Spargias | 1. The “standardized” TAVR... 957
Konstantinos Spargias | Director, Transcatheter... 1.568
1:56
George Dangas | FESC, FACC, Professor of... 1.153
2:10
L.Papavasileiou | 2. Pacemaker need after... 1.100
A.Kostopoulou | 3. Pacemaker indication:... 1.317
J.Velianou | 4. Why I want to move to lower... 1.126
V. Andoutsopoulou | 5. What bothers me to... 1.355
G.Dangas | 6. Antiplatelet/anticoagulation... 1.201
C.Arampatzis | 7. My best and worst TAVR... 1.084
K.Raisakis | 1. My best and worst TAVR case... 1.238
V.Tzifos | 2. My best and worst TAVR case... 1.145
P.Davlouros | 3. My best and worst TAVR... 1.217
M.Ηamilos | 4. My best and worst TAVR case... 945
A.Zacharoulis | 5. My best and worst TAVR... 1.038
A.Synetos | 6. My best and worst TAVR case... 1.250
K.Papadopoulos | 8. My best and worst TAVR... 1.161
Andreas Synetos | MD, PhD, FESC, Cardiologist,... 1.143
1:24
V.Ninios | 1. MitraClip patient selection-... 1.139
V.Ninios | 1. MitraClip patient selection-... 1.067
G.Pavlides | 3. Mitral interventions: a... 1.124
S.Pattakos | 6. Which “operable” DMR patient... 1.095
V.Ninios | 7. Mitraclip case-in-a-box 957
M.Vavouranakis | 1. How I select my TAVR... 1.072
K.Spargias | 2. How I select my TAVR device?... 1.062
D.Nikas | 4. How I select my TAVR device?... 1.040
D.Nikas | 4. How I select my TAVR device?... 808
Q&A / Comments 1.044
K. Papadopoulos - K.Spargias | 6. TAVR live-in-a-box 1.102
A.Gkouziouta | 1. The pathophysiology of... 1.227
I.Ikonomidis | 2. Assessing Tricuspid Regurgitation:... 1.160
P.Sfyridis | 3. The unforgotten valve: what... 1.033
V.Sachpekidis | 5. The multiple valve disease... 1.123
V.Ninios | 6. Mitraclip in TR 973
M.Chrissoheris | 7. FORMA in TR 1.058
G.Stavridis | 8. The isolated TR inoperable... 1.108
Q&A / Comments 1.114
VIDEO UNDER EDITING - L.Michalis | 1. TAVR:... 1.175
D.Angouras | 2. TAVR device durability.... 1.119
L.Poulimenos | 3. Paradox AVS: implications... 1.261
P.Dardas | 4. TAVR in Bicuspid and ViV 1.011
I.Iakovou | 5. VARC-2 and MVRC definitions 1.136
G.Bompas | 6. The concept of 4D imaging... 1.135
D.Nikas | 7. My best and worst TAVR case... 939
A.Ziakas | 3. My best and worst TAVR case... 1.192
N.Pilatis | 1. My best and worst TAVR case... 917
G.Karavolias | 4. My best and worst TAVR... 1.110
K.Kalogeras | 5. My best and worst TAVR... 856
D.Tsikaderis | 6. My best and worst TAVR... 1.144
A.Manginas | 7. My best and worst TAVR case... 1.129
P. Kourkoveli | 2. My best and worst TAVR... 1.093
Christina Chrysohoou, MD, Cardiologist,Heart... 1.046
49
Irene Mastorakou, Cardiac Radiologist,Director,... 946
123
Lampros Michalis, Professor of Cardiology,University... 1.262
49
James Velianou, MD, FRCPC,Interventional... 1.130
69
Georgios Katsimagklis, InterventionalCardiologist,... 1.456
109